Form D · Biotechnology
CB Biotechnologies Inc
Huntsville, AL · CIK 0001475850
Offering snapshot reported Nov 23, 2009 · SEC filing
- Reported sold
- $2.33M Offering amount: $2.33M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- May 19, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 23, 2009 | Initial | $2,327,600 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-136335
Source: Form D, filed Nov 23, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Han Jian | Director, Executive |
| Chiung Mei Lu | Director, Executive |
| Lonnie Mc Millian | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7712 Donegal Drive Se
Huntsville, AL, 35802
Huntsville, AL, 35802